BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23970488)

  • 1. Group sequential designs for three-arm 'gold standard' non-inferiority trials with fixed margin.
    Schlömer P; Brannath W
    Stat Med; 2013 Dec; 32(28):4875-89. PubMed ID: 23970488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of the two-stage group sequential three-arm gold-standard design for non-inferiority trials.
    Meis J; Pilz M; Herrmann C; Bokelmann B; Rauch G; Kieser M
    Stat Med; 2023 Feb; 42(4):536-558. PubMed ID: 36577519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group-sequential three-arm noninferiority clinical trial designs.
    Ochiai T; Hamasaki T; Evans SR; Asakura K; Ohno Y
    J Biopharm Stat; 2017; 27(1):1-24. PubMed ID: 26892481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blinded sample size re-estimation in three-arm trials with 'gold standard' design.
    Mütze T; Friede T
    Stat Med; 2017 Oct; 36(23):3636-3653. PubMed ID: 28608469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo.
    Pigeot I; Schäfer J; Röhmel J; Hauschke D
    Stat Med; 2003 Mar; 22(6):883-99. PubMed ID: 12627407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A general approach for sample size calculation for the three-arm 'gold standard' non-inferiority design.
    Stucke K; Kieser M
    Stat Med; 2012 Dec; 31(28):3579-96. PubMed ID: 22764073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A studentized permutation test for three-arm trials in the 'gold standard' design.
    Mütze T; Konietschke F; Munk A; Friede T
    Stat Med; 2017 Mar; 36(6):883-898. PubMed ID: 27859506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential parallel comparison design for "gold standard" noninferiority trials with a prespecified margin.
    Homma G; Daimon T
    Biom J; 2019 Nov; 61(6):1493-1506. PubMed ID: 31456230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation by simulation of clinical trial designs for evaluation of treatment during a viral haemorrhagic fever outbreak.
    Manchon P; Belhadi D; Mentré F; Laouénan C
    BMC Med Res Methodol; 2021 May; 21(1):98. PubMed ID: 33952195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A group sequential type design for three-arm non-inferiority trials with binary endpoints.
    Li G; Gao S
    Biom J; 2010 Aug; 52(4):504-18. PubMed ID: 20645389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and analysis of a 3-arm noninferiority trial with a prespecified margin for the hazard ratio.
    Hida E; Tango T
    Pharm Stat; 2018 Sep; 17(5):489-503. PubMed ID: 29984524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choosing and changing the analysis scale in non-inferiority trials with a binary outcome.
    Li Z; Quartagno M; Böhringer S; van Geloven N
    Clin Trials; 2022 Feb; 19(1):14-21. PubMed ID: 34693789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient group sequential designs when there are several effect sizes under consideration.
    Jennison C; Turnbull BW
    Stat Med; 2006 Mar; 25(6):917-32. PubMed ID: 16220524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-stage designs with small sample sizes.
    Kieser M; Rauch G; Pilz M
    J Biopharm Stat; 2023 Jan; 33(1):53-59. PubMed ID: 35612521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-stage, three-arm, adaptive test strategies for non-inferiority trials with an unstable reference.
    Brannath W; Scharpenberg M; Schmidt S
    Stat Med; 2022 Nov; 41(25):5033-5045. PubMed ID: 35979723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choice of delta noninferiority margin and dependency of the noninferiority trials.
    Tsong Y; Zhang J; Levenson M
    J Biopharm Stat; 2007; 17(2):279-88. PubMed ID: 17365224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group sequential multi-arm multi-stage survival trial design with treatment selection.
    Wu J; Li Y
    J Biopharm Stat; 2024 Jul; 34(4):453-468. PubMed ID: 37455424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal group-sequential designs for simultaneous testing of superiority and non-inferiority.
    Ohrn F; Jennison C
    Stat Med; 2010 Mar; 29(7-8):743-59. PubMed ID: 19941286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-arm group sequential designs with a simultaneous stopping rule.
    Urach S; Posch M
    Stat Med; 2016 Dec; 35(30):5536-5550. PubMed ID: 27550822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-stage drop-the-losers design for multi-arm clinical trials.
    Wason J; Stallard N; Bowden J; Jennison C
    Stat Methods Med Res; 2017 Feb; 26(1):508-524. PubMed ID: 25228636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.